Brief: Y-Mabs Therapeutics Maintaining Its Previous Financial Guidance For Year Ended Dec. 31, 2023
09/01/2024 11:55
Jan 9 (Reuters) - Y-mAbs Therapeutics Inc YMAB.O :
* Y-MABS THERAPEUTICS INC - MAINTAINING ITS PREVIOUSLY
ANNOUNCED
FINANCIAL GUIDANCE FOR YEAR ENDED DECEMBER 31, 2023
* Y-MABS THERAPEUTICS INC- FINANCIAL RUNWAY INTO 2027
Source text for Eikon: ID:
Further company coverage: YMAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Y-mAbs Therapeutics
See all newsY-mAbs Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Y-mAbs Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Y-mAbs Therapeutics' Q2 revenue falls 14%
Brief: Serb Pharmaceuticals Agrees To Acquire Y-Mabs Therapeutics
Y-mAbs Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary